Shiseido Company, Limited

The company traces its origin to 1872, when it opened in Tokyo as the country's first Western-style pharmacy [1]. Over the following century it moved from pharmaceuticals into cosmetics and grew into Japan's leading beauty manufacturer before expanding internationally. In the decades since, Shiseido has built its scale both organically and through acquisition, assembling a group that now reaches across the prestige, premium and fragrance segments of the global market.

Shiseido's owned prestige brands include its namesake Shiseido line, the high-end Japanese skincare and makeup house Clé de Peau Beauté, the American makeup brand NARS, the prestige skincare brand Drunk Elephant, and IPSA [4]. Beyond these directly owned brands, the group also operates a fragrance business under license, producing and distributing scents for fashion and designer names including Issey Miyake, Narciso Rodriguez, Serge Lutens and Tory Burch. In 2022 it added the microbiome-focused skincare brand Gallinée to its owned portfolio.

The distinction matters: licensed fragrance brands are marketed by Shiseido under agreement rather than owned outright, while brands such as NARS and Drunk Elephant were acquired as businesses.

Shiseido has reshaped its portfolio through a series of acquisitions and divestitures. In 2000 it acquired NARS Cosmetics, with founder François Nars selling the business through his holding company, Agora Cosmetics [5]. In 2017 it acquired the personalization technology firms MATCHCo and Giaran Inc., followed by Olivo Laboratories in 2018.

Its largest recent purchase came in 2019, when Shiseido agreed to acquire the prestige skincare brand Drunk Elephant; the deal was reported at around $845 million, though the company's own announcement of the agreement did not state a price [3]. In 2023 it added Dr. Dennis Gross Skincare to its prestige division [4].

Alongside these purchases, the group has sold off brands that no longer fit its strategy. It divested the professional skincare brands Carita and Decléor to L'Oréal in 2014 [4]. In 2021 it sold bareMinerals, BUXOM and Laura Mercier to the private-equity firm Advent International, and separately divested its personal care business to CVC [4]. Taken together, the moves reflect a shift toward higher-margin prestige skincare and away from mass-market and personal care lines.

Shiseido is a public company. Its shares are listed on the Tokyo Stock Exchange under the ticker 4911 and are a component of the Nikkei 225 and TOPIX indices [4].